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Endovascular treatment of a superior mesenteric
artery embolism in a high-risk Jehovah’s Witness
Christopher W. Seder, MD,a Michael Kramer, BS,b Maciej R. Uzieblo, MD,b and Paul Bove, MD,b
Royal Oak, Mich
Despite recent advances, emergent treatment of acute mesenteric ischemia carries a mortality of 40%-60%. Endovascular
therapy provides a reasonable option for high-risk patients with acute mesenteric ischemia who may not tolerate a
laparotomy. We present a case of successful endovascular embolectomy of the superior mesenteric artery, visceral aorta,
and right iliac artery in a high-risk octogenarian who refused the transfusion of blood products. As older patients present
with more comorbidities, endovascular techniques will play an increasingly large role in the treatment of acute mesenteric
ischemia. (J Vasc Surg 2009;49:1050-2.)Acute mesenteric ischemia (AMI) is generally caused by
an embolic or thrombotic occlusion of the superior mesen-
teric artery (SMA). Despite recent technological advances,
emergent treatment of AMI carries a mortality of 40%-
60%.1-3 Currently, the gold standard for treatment is ex-
ploratory laparotomy and surgical removal of the clot.
However, with the evolution of endovascular techniques,
patients in whom open embolectomy would be exceedingly
dangerous are being considered for catheter-based treat-
ment. We present a case of successful endovascular embo-
lectomy of the superior mesenteric artery, visceral aorta,
and right iliac artery in a high-risk octogenarian who re-
fused the transfusion of blood products.
CASE REPORT
The patient was an 83-year-old Jehovah’s Witness with a past
medical history significant for hypertension, diabetes mellitus,
chronic atrial flutter, and congestive heart failure who presented to
our emergency center with generalized weakness and vague ab-
dominal pain. She had an ejection fraction of 60% and a recent
stress test that demonstrated a small, fixed defect in the mid-
anteroseptal wall. Following an extensive work-up, she was found
to have second-degree heart block, was placed on intravenous
heparin, and was scheduled for pacemaker placement. She was not
on oral anticoagulants prior to admission. On hospital day six,
prior to pacemaker placement, her abdominal pain worsened and
she developed right-sided leg pain. The pain was not associated
with hematemesis, melena, or peritonitis. She became febrile and
developed a leukocytosis to 24,400/l. Her admission blood urea
nitrogen (BUN) and creatinine were 32 mg/dL and 1.1 mg/dL,
with an estimated admission glomerular filtration rate (GFR) of 57
ml/min. This rose to 33 mg/dL and 1.8 mg/dL (GFR  33
ml/min), respectively. Mesenteric ischemia was suspected, there-
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1050fore she was placed on wide-spectrum antibiotics and a vascular
surgery consultation was obtained. Dynamic contrast-enhanced
computed tomography revealed a mid-aortic thrombus with oc-
clusion of the right renal, superior mesenteric (SMA), and right
common iliac artery (Fig 1). Due to her advanced age and comor-
bid conditions, we felt an endovascular embolectomy without
thombolysis would provide her with the best opportunity for
recovery, as blood loss from thrombolytic-induced hemorrhage
and open SMA venting could be avoided.
She was taken to the operating room within eight hours of
consultation. We gained access through bilateral femoral artery
cut-downs to protect against distal emboli and to provide access for
both an aortic embolectomy catheter and a left renal-occlusive
catheter. An anterior-posterior aortogram confirmed a non-occlusive
thrombus in the visceral aorta that extended into the right common
iliac artery. Although the right renal artery and SMA were oc-
cluded, the left renal and celiac arteries were patent (Fig 2). A small
amount of SMA filling was noted via collateral vessels. An angled
Glidewire (Terumo, Ann Arbor, Mich) was advanced through a
Fig 1. Computed tomography demonstrating the visceral aortic
and right renal artery embolism.right-sided sheath, the thrombus was negotiated, and a Kumpe
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artery. A #4 French over-the-wire Fogarty balloon was advanced
over a V18 wire (Boston Scientific, Natick, Mass) and inflated to
protect the left kidney from emboli. An adequate length was
advanced into the renal artery to prevent dislodgement during the
aortic embolectomy. The left femoral sheath was converted to a
#12 French sheath, through which a Reliant balloon (Medtronic,
Santa Rosa, Calif) was used to perform a visceral aortic embolec-
tomy via a transverse arteriotomy. A moderate amount of clot was
returned; pathologic examination of the specimen revealed fresh
and organized clot. The SMA was then cannulated with an RDC
catheter (Medtronic), followed with a V18 wire, and a #4 Fogarty
was used to perform an SMA embolectomy. The left kidney was
re-perfused after a warm-ischemia time of approximately 25 min-
utes. A lateral SMA angiogram revealed residual ostial narrowing,
therefore we converted to a 0.035-inch platform and a 6 18 mm
balloon-expandable Palmaz Genesis stent (Cordis, Warren, NJ)
was advanced into the SMA and deployed. Follow-up angiogram
demonstrated continued ostial narrowing and a 70 mm Hg gradi-
ent. Due to stent availability, the SMA was reselected with a
0.018-inch platform and an overlapping 6  20 mm Palmaz Blue
stent was deployed with slight extension into the aorta. The
Fogarty catheter in the left renal artery was deflated, and repeat
angiogram revealed brisk antegrade flow through the recannulated
SMA (Fig 3), celiac, and left renal arteries. The right renal artery
was deemed unsalvageable due to the absence of blood flow on
computed tomography (CT) scan and the presence of ischemic
symptoms for approximately six days prior to vascular surgical
consultation. Bilateral common femoral embolectomies via the
Fig 2. Initial aortogram demonstrating visceral aortic, superior
mesenteric artery, and right renal artery embolus involvement.transverse arteriotomies, using #4 and #5 regular Fogarty cathe-ters, produced a moderate amount of clot. Follow-up angiogram
revealed patent bilateral common iliac and hypogastric arteries,
both femoral arteries had strong pulses, and both feet demon-
strated brisk capillary refill. The procedure took approximately 300
minutes, 270 mL of contrast was injected, and the blood loss was
300 mL. No cell salvage was used. Postoperatively, she developed
oliguric renal failure, with her BUN and creatinine rising to a
maximum of 62 mg/dL and 3.6 mg/dL (GFR  16 ml/min),
respectively. However, her urine output improved to greater than
0.5 ml/kg/hr and her BUN and creatinine returned to admission
levels without need for dialysis. She never required transfusion of
blood products, although her postoperative hemoglobin did drop
from a baseline of 9.4 g/dL to as low as 6.2 g/dL. Six weeks after
her combined open-endovascular SMA embolectomy, the patient
was discharged on warfarin to a subacute rehabilitation center. She
never received a pacemaker. Based on 27 months of clinical follow-
up, the patient has had no complications; however, no imaging
studies have been performed to confirm the patency of the SMA.
DISCUSSION
As medicine has evolved, the proportion of patients
with multiple comorbidities has risen. Endovascular tech-
niques provide a treatment option for this emerging patient
population who may not tolerate the morbidity associated
with open repair. Although limited to case reports,4-6 it
seems intuitive that the high perioperative mortality asso-
ciated with open repair in AMI could be lowered with
endovascular therapy, especially in high-risk subgroups. In
a review of 132 patients who underwent open repair for
AMI, previous cardiac illness (P .045), plasma urea levels
(P  .001), and small and large bowel involvement were
Fig 3. Superior mesenteric artery angiogram demonstrating suc-
cessful revascularization with embolectomy and stenting.identified as independent risk factors of perioperative mor-
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renal insufficiency (although no reports identified renal
emboli as a risk factor), making her a high-risk candidate for
open surgery. These factors combined with her refusal of
blood products prompted us to attempt an endovascular
approach to her AMI.
Currently, there is no definitive evidence supporting
the use of an endovascular approach in acute or chronic
mesenteric ischemia. If there is any doubt regarding the
viability of the bowel, it must be examined via laparotomy
or laparoscopy. In the 48 hours following surgery, our
patient’s abdomen became significantly less tender and
distended. A patient must be monitored closely and dem-
onstrate signs of ongoing clinical improvement for at least
48 hours prior to determining that the patient has no
irreversible bowel injury. This period allows enough time
for infarcted bowel to manifest itself as pain, leukocytosis,
or hemodynamic instability. As older patients present with
more comorbidities, endovascular techniques are likely to
play an increasingly large role in the treatment of acute
mesenteric ischemia.
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